SMN2 and proximal spinal muscular atrophy: The only study to robustly determine SMN protein and RNA levels in a large number of post-mortem spinal cord samples, from unaffected individuals and patients with and without SMA, found that SMN levels were especially high in prenatal controls, followed by a quick decline after birth (Ramos et al., 2019).